Dr. Funnell introduce herself and talks about how she is active in a variety behavioral and education studies and as a CDE for 27 years, she’s seen a lot of changes. More videos with Dr. Funnell: Martha Funnell Q1 Changes in Diabetes Education Martha Funnell Q2 How Can You Change Behavior? Martha …
Read More »Diabetes In Control
Editor’s Desk, DCMS #99
This week we are honored to present an excerpt from Diabetic Emergencies: Diagnosis and Clinical Management. This new text provides highly practical, clear-cut clinical guidance for serious diabetic emergencies like ketoacidosis, hyperosmolar coma and severe hyper- and hypoglycemia, and the best methods of both managing the emergencies and administering appropriate follow-up …
Read More »Diabetic Emergencies – Diagnosis and Clinical Management: Diabetic Ketoacidosis in Adults
Diabetic ketoacidosis (DKA) is an acute complication of diabetes mellitus. It is characterized by the triad of hyperglycemia, ketosis, and metabolic acidosis.1
Read More »Leveraging Weight Loss in the Treatment of Type 2 Diabetes 2012 Part 1 of 4
In this week’s set of Homerun Slides, we begin a four part series on how weight gain affects the overall health of our overweight and obese type 2 diabetes patients and the many ways the positive effects of weight loss can be maximized to improve health….
Read More »Dr. Gregory Frost Introduction
Dr. Frost introduces himself to us and talks about Halozyme, and how the company tries to "think outside the cell," working to "smooth out" the blood sugar rollercoaster that diabetes patients too often find themselves on. More videos with Dr. Frost: Dr. Gregory Frost Q1 What Is Halozyme’s Current Focus? Dr. Gregory Frost …
Read More »Dr. Gregory Frost Q1 What Is Halozyme’s Current Focus?
Dr. Frost talks about the background and history of Halozyme’s product development and the critical need for more effective insulins. More videos with Dr. Frost: Dr. Gregory Frost Introduction Dr. Gregory Frost Q2 Who Participated in the Study and How Did They Do? Dr. Gregory Frost Q3 Starting Baselines and …
Read More »Dr. Gregory Frost Q2 Who Participated in the Study and How Did They Do?
Dr. Frost goes over some of the details of the Halozyme study including how researchers looked at both type 1 and type 2 patients, the incidence of hypoglycemia, and the overall positive results. More videos with Dr. Frost: Dr. Gregory Frost Introduction Dr. Gregory Frost Q1 What Is Halozyme’s Current …
Read More »Dr. Gregory Frost Q3 Possible Breakthrough with an Insulin Additive
Dr. Frost talks about the results of the Halozyme study and the positive results, including a drop in A1c from the 8 range in type 2 diabetes patients to around 6.8. He also lets us know how the reduced use of better-designed insulins could even result in some weight loss, …
Read More »GLP-1 Agonist Effects on Glucagon Suppression
Alan Mathis, PharmD Candidate 2013, University of Florida College of Pharmacy The pathophysiology of type-2 diabetes is characterized by insulin resistance and beta-cell dysfunction. In addition, the presence of high levels of glucagon in the blood also seems to play an important role in the disease. Glucagon-like peptide-1 (GLP-1) is a …
Read More »Letter from the Editor, #640: Is There a New Cure for Type 1 with an Old Vaccine?
This week, there’s a lot in the press about the use of an old TB vaccine to "cure" type 1 diabetes. Our publisher, Steve Freed, has put together a fantastic synopsis that cuts through the hype and delivers the real story: check out Item #1, Faustman’s Type 1 Diabetes Cure …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.